343 related articles for article (PubMed ID: 17299378)
1. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
[TBL] [Abstract][Full Text] [Related]
2. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
3. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
5. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
7. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
[TBL] [Abstract][Full Text] [Related]
10. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
12. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
Santos AC; Lopes C; Guimarães JT; Barros H
Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
[TBL] [Abstract][Full Text] [Related]
13. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.
Onat A; Can G; Hergenç G; Küçükdurmaz Z; Uğur M; Yüksel H
Cardiology; 2010; 115(4):297-306. PubMed ID: 20395681
[TBL] [Abstract][Full Text] [Related]
14. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
15. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
16. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
17. Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks.
Onat A; Hergenc G; Dursunoglu D; Ordu S; Can G; Bulur S; Yüksel H
Alcohol; 2008 Nov; 42(7):593-601. PubMed ID: 18835594
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlates of metabolic syndrome (MS) in older adults.
Cankurtaran M; Halil M; Yavuz BB; Dagli N; Oyan B; Ariogul S
Arch Gerontol Geriatr; 2006; 42(1):35-45. PubMed ID: 16046242
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
